Congressional Research Service Issues Insight White Paper on TRICARE's Next Generation Contracts

WASHINGTON, April 22 -- The Congressional Research Service issued the following Insight white paper on the TRICARE's next generation contracts (No. IN11719) on April 21, 2023, by Bryce H. P. Mendez, defense health care policy analyst.

Here are excerpts:

* * *

TRICARE's Next Generation Contracts: T-5

The Department of Defense (DOD) administers a Military Health System (MHS) that provides health care entitlements authorized in Title 10 of the U.S. Code (Chapters 55 and 56) and is organized under the TRICARE program. The TRICARE program offers health care benefits to approximately 9.6 million beneficiaries in DOD hospitals and clinics (i.e., military treatment facilities or MTFs) and through networks of participating civilian health care providers. The Defense Health Agency (DHA) administers the TRICARE program and contracts with several managed care support organizations to deliver health care entitlements.

In recent years, Congress has demonstrated sustained interest in the MHS by enacting TRICARE reforms (see Section 705 of the National Defense Authorization Act for 2017; P.L. 114-328) to require increased access to care, improved health outcomes and health care quality, enhanced beneficiary experience, and lower per capita costs. Many of these reforms are, or are in the process of being, integrated into the TRICARE contracts. On April 15, 2021, DHA released a request for proposals (RFP) for the next generation of TRICARE contracts, called T-5, which incorporate congressionally mandated reforms.

This Insight provides an overview of T-5, DHA's acquisition strategy, and the timeline for awarding the new contracts.

What is T-5?

DHA envisions that T-5 would supplement existing MTF resources with contracted networks of U.S. health care providers to achieve an "integrated healthcare delivery system." DHA intends to award one T-5 contract for each of its two geographic regions (TRICARE East and TRICARE West). T-5 contract awardees would perform tasks organized under a variety of categories, many of which existed in previous iterations of TRICARE contracts, including

* claims processing,

* enrollment process management,

* health care finder and referral services,

* establishment and maintenance of adequate provider networks,

* customer services for beneficiary network providers,

* medical management, and

* clinical quality improvement programs.

The RFP outlines contract requirements that DHA anticipates using to address congressionally directed reforms that stipulate value-based care and commercial health insurance best-practices. These requirements include

* "advanced primary care practices" (also called patient-centered medical homes) in TRICARE networks;

* "advanced care management" (predictive analytics and care collaboration tools to manage patients with complex needs);

* incentives to "motivate providers to invest in and adopt new approaches to care delivery;"

* partnerships with "high-performing, high-value" providers/facilities to serve as "Clinical Centers of Excellence";

* alternative provider payment and reimbursement models; and

* cooperation in future demonstration projects that contract with other health care organizations (separate from T-5) to provide TRICARE benefits.

T-5 is to provide services for beneficiaries in the 50 states and District of Columbia. The TRICARE Overseas Program contract (i.e., TOP-2021) offers services for beneficiaries residing in other U.S. commonwealths and territories and outside the United States.

DHA's acquisition strategy and timeline for T-5

DHA's 2020 report to the Senate Armed Services Committee on the T-5 contract states the new contracts are to "provide the best readiness of the military at the best price in an integrated system that is responsive to beneficiary experience of care." The RFP announcement states "full and open competitive source selection, using best value trade-off procedures" will be used to award the contract. The T-5 contracts have a potential 10-year performance period, including

* transition-in activities (12 months);

* eight option periods for health care delivery (1-year periods);

* transition-out activities (18 months); and

* if needed, a 6-month extension of services.

On December 22, 2022, DOD announced selectees and the estimated value of the T-5 contracts:

* Humana Government Business, TRICARE East, ($70.9 billion), and

* TriWest Healthcare Alliance, TRICARE West, ($65.1 billion).

Health Net Federal Services, the current TRICARE West contractor under the T-2017 contracts, filed a bid protest with the Government Accountability Office (GAO) on January 17, 2023. GAO dismissed the bid protest after DOD reportedly "elected to take corrective action to address concerns in the procurement." On April 20, 2023, DHA "reaffirmed the award of the TRICARE West region" to TriWest Healthcare Alliance.

Figure 1 depicts estimated T-5 contract milestones, from 2019 through 2032, with all options exercised.

* * *

Figure 1. DHA T-5 Acquisition Timeline

Source: CRS graphic based on email communication with DHA officials in September 2020; SAM.gov, Notice of Solicitation: HT9402-20-R-0005, "Request for Proposals TRICARE Managed Care Support (T-5)," April 15, 2021; DOD, "DoD Awards $136 Billion TRICARE Managed Care Support Contracts," press release, December 22, 2022; GAO Bid Protest Decisions and the Docket, "Health Net Federal Services, LLC (HT9402-20-R-0005)," February 9, 2023; DHA, "Defense Health Agency Reaffirms Award of TRICARE West Region Contract to TriWest Healthcare Alliance," April 20, 2023.

Note: Dash line = hypothetical milestone dates.

* * *

DHA evaluation of T-5 contract bids

In evaluating submitted bids for the T-5 contracts, DHA assessed four factors that represent best value to the government:

* Technical Rating (how well the technical solution will meet the government's requirements) and Technical Risk Rating (how much risk the technical solution poses to the contract's schedule, cost, performance, or government oversight);

* Past Performance (how well an offeror has conducted recent, relevant work);

* Price/Cost to the government; and

* Small Business Participation.

A single vendor may not be awarded T-5 contracts for both TRICARE regions.

Considerations for Congress

Congress may consider the following lines of inquiry to oversee DHA's transition to the T-5 contracts.

* On December 23, 2022, DHA issued an extension of the T-2017 contracts to no later than June 2025. DHA stated, "several projects to support T-5 requirements development were cancelled, disapproved, delayed, or reduced in scope, which negatively impacted T-5 outcomes and placed the acquisition schedule at risk." Is DHA capturing lessons learned during the T-5 acquisition process for application in the procurement of the next iteration of TRICARE contracts?

* What actions will DHA implement to ensure beneficiaries receive seamless and timely access to quality care if there is an additional bid protest filed or potential litigation, and during the contract transition process?

* The T-5 acquisition strategy summary states DHA's plan to "seek any necessary legislative relief" to implement further TRICARE reforms. What new authorities are needed to make such reforms?

* * *

The white paper is posted at: https://crsreports.congress.gov/product/pdf/IN/IN11719